These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23875732)

  • 1. Oxysterol receptors and their therapeutic applications in cancer conditions.
    De Boussac H; Alioui A; Viennois E; Dufour J; Trousson A; Vega A; Guy L; Volle DH; Lobaccaro JM; Baron S
    Expert Opin Ther Targets; 2013 Sep; 17(9):1029-38. PubMed ID: 23875732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
    Bovenga F; Sabbà C; Moschetta A
    Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterol receptors, AKT and prostate cancer.
    Dufour J; Viennois E; De Boussac H; Baron S; Lobaccaro JM
    Curr Opin Pharmacol; 2012 Dec; 12(6):724-8. PubMed ID: 22819197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting liver X receptors in human health: deadlock or promising trail?
    Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM
    Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of liver X receptors and their ligands in cancer.
    Lin CY; Vedin LL; Steffensen KR
    Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor: from metabolism to cancer.
    Venteclef N; Ferré P
    Biochem J; 2014 Apr; 459(2):e1-3. PubMed ID: 24678940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective liver X receptor modulators (SLiMs): what use in human health?
    Viennois E; Mouzat K; Dufour J; Morel L; Lobaccaro JM; Baron S
    Mol Cell Endocrinol; 2012 Apr; 351(2):129-41. PubMed ID: 21907760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids, LXRs and prostate cancer: are HDACs a new link?
    Hoang JJ; Baron S; Volle DH; Lobaccaro JM; Trousson A
    Biochem Pharmacol; 2013 Jul; 86(1):168-74. PubMed ID: 23618920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors.
    Tontonoz P
    Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis.
    Ducheix S; Lobaccaro JM; Martin PG; Guillou H
    Chem Phys Lipids; 2011 Sep; 164(6):500-14. PubMed ID: 21693109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon.
    Vedin LL; Gustafsson JÅ; Steffensen KR
    Mol Carcinog; 2013 Nov; 52(11):835-44. PubMed ID: 22610535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells.
    Ma L; Vidana Gamage HE; Tiwari S; Han C; Henn MA; Krawczynska N; Dibaeinia P; Koelwyn GJ; Das Gupta A; Bautista Rivas RO; Wright CL; Xu F; Moore KJ; Sinha S; Nelson ER
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35569056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LXR-dependent and -independent effects of oxysterols on immunity and tumor growth.
    Traversari C; Sozzani S; Steffensen KR; Russo V
    Eur J Immunol; 2014 Jul; 44(7):1896-903. PubMed ID: 24777958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural modulators of liver X receptors.
    Huang C
    J Integr Med; 2014 Mar; 12(2):76-85. PubMed ID: 24666673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.